Latest DEF 14A proxy statements

GitLab Inc. has issued its 2026 proxy statement detailing director elections, executive compensation, and the ratification of its independent auditor.

Everpure reports strong fiscal 2026 performance with $3.7B in revenue and outlines executive compensation tied to growth.

Sprinklr, Inc. has issued its 2026 proxy statement detailing director elections, executive compensation, and auditor ratification.

WidePoint Corporation schedules its 2026 Annual Meeting of Stockholders for June 19, 2026, to address director elections and auditor ratification.

PAVmed Inc. has issued its 2026 proxy statement detailing proposals for director elections, an ESPP amendment, and auditor ratification.

Bakkt's 2026 proxy statement outlines the company's strategic pivot, board restructuring, and the acquisition of Distributed Technologies Research (DTR).

CION Investment Corporation has scheduled its 2026 Annual Meeting of Shareholders for June 25, 2026, to elect two directors and ratify its independent auditor.

Syndax Pharmaceuticals announces its 2026 Annual Meeting of Stockholders to be held virtually on June 10, 2026.

DXP Enterprises, Inc. announces its 2026 Annual Meeting of Shareholders to address director elections, executive compensation, and auditor ratification, following a strong fiscal year 2025 performance.

Ocular Therapeutix, Inc. filed its 2026 proxy statement detailing executive compensation, director elections, and a proposal to increase the 2021 Stock Incentive Plan by 10 million shares.

Comstock Holding Companies, Inc. announces its 2026 Annual Meeting of Stockholders to be held on June 17, 2026.

United Parks & Resorts Inc. releases its 2026 proxy statement detailing director elections, executive compensation, and governance updates following a challenging 2025 fiscal year.

Kaltura, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 24, 2026.

XPEL, Inc. announces its 2026 Annual Meeting of Stockholders to be held on June 10, 2026, covering director elections, auditor ratification, and executive compensation.

Contango Silver & Gold Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on June 18, 2026.

Kiora Pharmaceuticals announces its 2026 Annual Meeting of Stockholders to be held on June 10, 2026, featuring proposals for director elections, executive compensation, and an equity plan amendment.

Alto Ingredients, Inc. reported a significant financial turnaround in 2025, driven by strategic initiatives, increased net income, and strong Adjusted EBITDA growth.

Grindr Inc. announces its 2026 Annual Meeting, seeking shareholder approval for an equity incentive plan amendment and the election of eight director nominees.

AtlasClear Holdings, Inc. has issued its 2026 proxy statement seeking shareholder approval for director elections, an equity incentive plan amendment, and auditor ratification.

Adagio Medical Holdings, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 16, 2026.

Optimum Communications, Inc. has released its 2026 proxy statement detailing director elections, executive compensation, and governance practices.

Lucid Diagnostics Inc. has filed its proxy statement for the 2026 Annual Meeting, seeking approval for a capital increase and director elections.

TELA Bio, Inc. announces its 2026 Annual Meeting of Stockholders, featuring a significant board refreshment and a proposal to increase equity incentive plan shares.

Supernus Pharmaceuticals schedules its 2026 Annual Meeting of Stockholders for June 18, 2026, to address director elections, executive compensation, and equity plan expansion.

ACCESS Newswire Inc. has issued its 2026 proxy statement, outlining the agenda for the upcoming virtual annual meeting of stockholders scheduled for June 26, 2026.

Rackspace Technology, Inc. has issued its 2026 Proxy Statement, outlining key proposals including director elections, auditor ratification, and an amendment to its 2020 Equity Incentive Plan.

Airgain, Inc. announces its 2026 Annual Meeting of Stockholders to elect directors, ratify auditors, and approve an amended 2016 Incentive Award Plan.

Eledon Pharmaceuticals announces its 2026 Annual Meeting of Stockholders to elect directors, increase authorized shares, and ratify its auditor.

Riot Platforms announces its 2026 Annual Meeting, focusing on board declassification, executive compensation, and equity plan expansion.

Annovis Bio, Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and proposed equity plan amendments.